S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:MJN

Mead Johnson Nutrition (MJN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$89.98
$89.98
50-Day Range
N/A
52-Week Range
$69.25
$94.40
Volume
N/A
Average Volume
3.24 million shs
Market Capitalization
N/A
P/E Ratio
24.25
Dividend Yield
N/A
Price Target
N/A
MJN stock logo

About Mead Johnson Nutrition Stock (NYSE:MJN)

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

MJN Stock News Headlines

Reckitt/Mead Johnson Nutrition Recalls Baby Formula Powder
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Mead Johnson Nutrition Co - MJN - DELISTED
Enfamil Baby Formula Review 2023
Andrew Bischof
Mead Johnson Nutrition
Baby Food Pediatric Nutrition Market by 2031
Mead Senior High School
See More Headlines
Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mead Johnson Nutrition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/27/2017
Today
4/19/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Packaged Foods & Meats
CUSIP
58283910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Peter Kasper Jakobsen
    President, Chief Executive Officer, Director
  • Michel M.G. Cup
    Chief Financial Officer, Executive Vice President
  • Charles M. Urbain
    Chief Operating Officer, Executive Vice President
  • Patrick M. Sheller
    Senior Vice President, General Counsel, Secretary
  • James E. Shiah
    Senior Vice President, Corporate Controller
  • James Jeffrey Jobe
    Senior Vice President - Technical Operations
  • Ian Eric Ormesher
    Senior Vice President- Global Human Resources
  • Dirk Hondmann Ph.D.
    Chief Scientific Officer
  • James M. Cornelius
    Non-Executive Chairman of the Board
  • Elliot Sigal M.D. Ph.D.
    Director

MJN Stock Analysis - Frequently Asked Questions

How were Mead Johnson Nutrition's earnings last quarter?

Mead Johnson Nutrition CO (NYSE:MJN) released its earnings results on Thursday, April, 27th. The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.79 by $0.01. The firm had revenue of $883.50 million for the quarter, compared to analysts' expectations of $911.63 million. The firm's quarterly revenue was down 8.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.87 EPS.

Is Mead Johnson Nutrition a good dividend stock?

Mead Johnson Nutrition (NYSE:MJN) pays an annual dividend of $1.65 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 44.47%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for MJN.

What other stocks do shareholders of Mead Johnson Nutrition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mead Johnson Nutrition investors own include Ford Motor (F), Gilead Sciences (GILD), Caterpillar (CAT), CenterPoint Energy (CNP), General Electric (GE), Procter & Gamble (PG), QUALCOMM (QCOM), AT&T (T), Bristol-Myers Squibb (BMY) and Cisco Systems (CSCO).

This page (NYSE:MJN) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners